Pharmaron Beijing Co., Ltd. 康龍化成 (北京) 新藥技術股份有限公司

Pay for financial year ended 2024-12-31

Source: Annual report

Note: while most data are extracted from annual reports, some data in these tables may have been taken from supplemental filings made in response to complaints to SEHK by our volunteer editors. Please report any errors.

Name Last
position
Fees Salary &
benefits
Bonus Retire Share-
based
Total

CNY '000

Supervisors

1 Feng, Shu (1985-04) 馮書 Supervisor
2 Yang, Kexin (1963) 楊珂新 Sup Ch 1,299 100 1,399
3 Zhang, Lan (1982) 張嵐 Supervisor 585 180 765
Total 0 1,884 280 0 0 2,164

Directors

4 Hu, Baifeng 胡柏風 NED
5 Li, Jiaqing (1973) 李家慶 NED
6 Li, Lihua (Pharmaron Beijing) 李麗華 INED 300 300
7 Lou, Boliang 樓柏良 Ch, CEO, Co-Fdr 2,213 2,213
8 Lou, Xiaoqiang 樓小強 Pres, Co-Fdr 1,913 1,913
9 Tsang, Benson Kwan Hung 曾坤鴻 INED 300 300
10 Yu, Jian (1973) 余堅 INED 300 300
11 Zheng, Bei 鄭北 ED, VP, Co-Fdr 1,600 1,600
12 Zhou, Qilin 周其林 INED 277 277
Total 1,177 5,726 0 0 0 6,903
Grand total 1,177 7,610 280 0 0 9,067

Main board pay history

Click on the year-end to see the pay details.

CNY'000

Year-end Fees Salary &
benefits
Bonus Retire Share-
based
Total
2024-12-31 1,177 5,726 0 0 0 6,903 Report
2023-12-31 1,200 5,716 0 0 0 6,916 Report
2022-12-31 1,202 5,753 0 0 0 6,955 Report
2021-12-31 880 5,773 15,000 0 0 21,653 Report
2020-12-31 921 5,716 7,000 0 0 13,637 Report
2019-12-31 613 5,470 2,880 0 0 8,963 Report
Total 5,993 34,154 24,880 0 0 65,027

Want to see more years here? volunteer to be a Webb-database editor and add the data from annual reports!


Copyright & disclaimer, Privacy policy

Back to top